The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $3.60 in the prior trading day, Cardlytics Inc (NASDAQ: CDLX) closed at $3.38, down -5.98%. In other words, the price has decreased by -$5.98 from its previous closing price. On the day, 1.04 million shares were traded. CDLX stock price reached its highest trading level at $3.62 during the session, while it also had its lowest trading level at $3.315.
Ratios:
Our goal is to gain a better understanding of CDLX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.18 and its Current Ratio is at 1.18. In the meantime, Its Debt-to-Equity ratio is 3.18 whereas as Long-Term Debt/Eq ratio is at 2.49.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Evercore ISI on October 11, 2024, initiated with a In-line rating and assigned the stock a target price of $4.
On August 16, 2024, Northland Capital Downgraded its rating to Market Perform which previously was Outperform but kept the price unchanged to $5.
BofA Securities Downgraded its Neutral to Underperform on August 15, 2024, whereas the target price for the stock was revised from $4 to $3.50.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 15 ’24 when DeSieno Alexis sold 25,118 shares for $3.43 per share. The transaction valued at 86,155 led to the insider holds 116,481 shares of the business.
DeSieno Alexis bought 25,118 shares of CDLX for $86,165 on Nov 15 ’24. On Oct 24 ’24, another insider, Gupta Amit, who serves as the Chief Executive Officer of the company, sold 22,607 shares for $3.85 each. As a result, the insider received 86,924 and left with 178,519 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDLX now has a Market Capitalization of 171779712 and an Enterprise Value of 326736864. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.55 while its Price-to-Book (P/B) ratio in mrq is 2.44. Its current Enterprise Value per Revenue stands at 1.113 whereas that against EBITDA is -8.926.
Stock Price History:
Over the past 52 weeks, CDLX has reached a high of $20.52, while it has fallen to a 52-week low of $2.89. The 50-Day Moving Average of the stock is -9.25%, while the 200-Day Moving Average is calculated to be -55.78%.
Shares Statistics:
The stock has traded on average 865.69K shares per day over the past 3-months and 1365270 shares per day over the last 10 days, according to various share statistics. A total of 50.82M shares are outstanding, with a floating share count of 48.29M. Insiders hold about 4.98% of the company’s shares, while institutions hold 60.98% stake in the company. Shares short for CDLX as of 1730332800 were 7096521 with a Short Ratio of 8.20, compared to 1727654400 on 8285405. Therefore, it implies a Short% of Shares Outstanding of 7096521 and a Short% of Float of 16.700001.
